These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12114299)

  • 1. Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome.
    Chapman J; Shoenfeld Y
    Ann N Y Acad Sci; 2002 Jun; 966():415-24. PubMed ID: 12114299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS dysfunction in the antiphospholipid syndrome.
    Katzav A; Chapman J; Shoenfeld Y
    Lupus; 2003; 12(12):903-7. PubMed ID: 14714909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from experimental APS models.
    Shoenfeld Y; Ziporen L
    Lupus; 1998; 7 Suppl 2():S158-61. PubMed ID: 9814695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome.
    Katzav A; Litvinjuk Y; Pick CG; Blank M; Shoenfeld Y; Sirota P; Chapman J
    Behav Brain Res; 2006 May; 169(2):289-93. PubMed ID: 16530276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies.
    Shrot S; Katzav A; Korczyn AD; Litvinju Y; Hershenson R; Pick CG; Blank M; Zaech J; Shoenfeld Y; Sirota P; Chapman J
    Lupus; 2002; 11(11):736-43. PubMed ID: 12475004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.
    Yelnik CM; Kozora E; Appenzeller S
    Curr Rheumatol Rep; 2016 Feb; 18(2):11. PubMed ID: 26923254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid syndrome: state of the art with emphasis on laboratory evaluation.
    Greaves M
    Haemostasis; 2000; 30 Suppl 2():16-25. PubMed ID: 11251337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome.
    Krause I; Blank M; Fraser A; Lorber M; Stojanovich L; Rovensky J; Shoenfeld Y
    Immunobiology; 2005; 210(10):749-54. PubMed ID: 16325493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibody syndrome.
    Kutteh WH; Hinote CD
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.
    Chapman J; Rand JH; Brey RL; Levine SR; Blatt I; Khamashta MA; Shoenfeld Y
    Lupus; 2003; 12(7):514-7. PubMed ID: 12892390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology.
    Sanna G; Bertolaccini ML; Hughes GR
    Ann N Y Acad Sci; 2005 Jun; 1051():465-86. PubMed ID: 16126988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.
    Ziporen L; Shoenfeld Y; Levy Y; Korczyn AD
    J Clin Invest; 1997 Aug; 100(3):613-9. PubMed ID: 9239409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological presentations of the antiphospholipid syndrome: three illustrative cases.
    De Maeseneire Ch; Duray MC; Rutgers MP; Gille M
    Acta Neurol Belg; 2014 Jun; 114(2):117-23. PubMed ID: 24464766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiphospholipid syndrome.
    Wautrecht JC
    Acta Neurol Belg; 2002 Dec; 102(4):158-62. PubMed ID: 12534241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies?
    Noureldine MH; Harifi G; Berjawi A; Haydar AA; Nader M; Elnawar R; Sweid A; Al Saleh J; Khamashta MA; Uthman I
    Lupus; 2016 Nov; 25(13):1397-1411. PubMed ID: 27225212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetric antiphospholipid syndrome: an update on pathophysiology and management.
    Ernest JM; Marshburn PB; Kutteh WH
    Semin Reprod Med; 2011 Nov; 29(6):522-39. PubMed ID: 22161465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.